Multitarget Stereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
A legfontosabb adatok
- Ki végzi
- Beijing Tiantan Hospital
- Hol
- Beijing (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 5 fő, tervezett
- Kezdés
- 2024. okt. 1.
- Tervezett befejezés
- 2026. márc.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- New Target DBS
- CM-DBS
- Sham Stimulation
- A regiszteradat frissítve
- 2025. május 22.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with severe Tourette syndrome whose tics have not improved enough with usual treatment. They will have brain recordings and deep brain stimulation (DBS), an implanted device that sends small electrical pulses to the brain.
- Életkor
- 18 to 60 years
- Nem
- All sexes
- A betegség stádiuma
- Tourette syndrome diagnosed by DSM-V criteria. Several motor tics and at least one vocal tic, starting before age 18 and lasting more than 1 year. YGTSS total score above 35 for at least 1 year, motor tic score of 15 or more. Tics must be the main cause of disability.
- Korábbi kezelés
- Standard medicines and behavioral therapy have not helped enough. Any other medical, neurological or mental health conditions must be treated and stable for at least 6 months.
A részvétel fő kizáró okai
- Risk of suicide (score of 3 or more on the suicide items of the HAMD scale)
- Drug or alcohol dependence in the past 6 months
- Abnormal brain structure on CT or MRI, or cannot have brain surgery, CT/MRI or general anesthesia
- Factitious disorder, malingering or psychogenic tics
- Pregnancy or breastfeeding, or expected survival of less than 12 months
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Age between 18 and 60 years
- Diagnosis of Tourette Syndrome according to DSM-V criteria, defined as:; The presence of multiple motor tics and at least one vocal tic at some point (not necessarily simultaneous); Tics that have persisted for more than 1 year from their onset; Onset of tics occurring before the age of 18; The disorder is not attributable to the physiological effects of a substance or another medical condition
- A Yale Global Tic Severity Scale (YGTSS) total score greater than 35 (on a scale of 0-50) for at least 1 year, with a motor tic score of ≥15, and tics being the primary cause of disability
- Inadequate response to conservative treatments (standard pharmacological and behavioral therapy)
- Disease duration of more than 1 year
- Any coexisting medical, neurological, or psychiatric disorders have been treated and remain stable for at least 6 months
- A stable psychosocial environment
- Neuropsychological evaluation demonstrating that the candidate can tolerate the surgical procedure, postoperative follow-up, and potential adverse events
- The participant, or his/her legal representative, is able to provide written informed consent
Ki nem vehet részt
- Pregnancy or lactation, or a positive pregnancy test prior to randomization
- History of drug or alcohol dependence within the past 6 months
- Presence of any condition that could lead to surgical failure or interfere with postoperative management
- Diagnosis of factitious disorder, malingering, or psychogenic tics
- Contraindications to neurosurgical procedures (e.g., history of cerebral infarction, hydrocephalus, cerebral atrophy, or post-stroke sequelae)
- Contraindications to general anesthesia (e.g., severe arrhythmia, severe anemia, hepatic or renal dysfunction)
- Any other condition that, in the investigator's judgment, renders the candidate unsuitable for participation or poses a significant risk (e.g., inability to understand study procedures or poor adherence)
- Presence of suicidal risk, defined as a score of ≥3 on the suicide-related items of the Hamilton Depression Rating Scale (HAMD)
- Abnormal brain structure as indicated by CT or MRI scans
- Contraindications for CT/MRI scanning (e.g., claustrophobia)
- Expected survival of less than 12 months
- Participation in other interventional clinical studies that may influence outcome assessments
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 60 év között vagy?
Helyszínek itt: Kína
- Beijing Tiantan Hospital,Capital Medical UniversityBeijing, KínaContact: Jianguo Zhang, M.D., Ph.D.Résztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to investigate the neural mechanisms underlying Tourette syndrome (TS) and see if personalized deep brain stimulation (DBS) can help reduce tics in TS patients and improve related issues like anxiety, attention problems, and obsessive-compulsive behaviors.
A teljes eredeti leírásKevesebb
In this study, researchers will use stereoelectroencephalography (SEEG) and electrocorticography (ECoG) to record brain activity in key areas involved in movement and emotion, including the nucleus accumbens (NAc), anterior limb of the internal capsule (ALIC), insular cortex, anterior cingulate cortex (ACC), central medial thalamic nucleus (CM), globus pallidus internus (GPi), and motor cortex (M1). They will test stimulation in these areas to evaluate acute therapeutic effect for each target and to identify a new effective new target.
Later, participants will receive DBS treatment under three different conditions, each for 1 month to identify the optimal target:
1. Stimulation at the new target, 2. Stimulation at the CM, 3. Sham stimulation (does not actually stimulate).
Finally, DBS will be continued at the optimal target for an additional three months to confirm its therapeutic impact.
By analyzing the brain activity and comparing these conditions, the study will clarify the neural mechanisms underlying TS and learn which target works best to lower tics and improve overall quality of life for TS patients.
A vizsgálat 3 csoportja
- New Target DBSA vizsgált kezelés
Participants in this arm will receive active deep brain stimulation targeted to a novel brain region. The new target is identified through electrophysiological brain mapping and 24-hour stimulation. Stimulation parameters (frequency, voltage, pulse width) will be individually optimized based on mapping results.
- CM-DBSMár használt kezelés, összehasonlításként
Participants in this arm will receive active deep brain stimulation at the central medial thalamic nucleus (CM), a well-established target for TS treatment. Stimulation settings are determined during electrophysiological brain mapping and 24-hour stimulation. This arm serves as the active comparator, enabling the evaluation of relative efficacy and safety between the conventional CM target and the new target intervention.
- Sham StimulationSzínlelt kezelés, összehasonlításként
Participants in this arm will undergo identical surgical procedures and follow-up assessments as in the active stimulation arms but will receive sham (inactive) stimulation. This arm is designed to control for placebo effects and ensure that any observed improvements in TS symptoms are attributable to the active interventions.
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- MultitArget STereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT06889480: ki vehet részt
- A regiszteradat frissítve
- 2025. május 22.